News
Full coverageNovartis Bets $8.7 Billion on Gene-Therapy Company
Wall Street Journal Apr 9, 2018
Novartis bets big on gene therapy with $8.7 billion AveXis deal
Reuters Apr 9, 2018
Novartis just handed out a $8.7 billion endorsement for new therapies that are changing how we treat genetic diseases
Business Insider Apr 9, 2018
More ArticlesWhy Novartis Is Paying $8.7 Billion for a Gene Therapy Developer You've Never Heard Of
Fortune Apr 9, 2018
Novartis enters deal to acquire gene therapy company AveXis for $8.7 billion
CNBC Apr 9, 2018
Brainstorm Health: Keytruda Lung Cancer Trial, Virtual PT, Novartis Gene Therapy Deal
Fortune Apr 9, 2018
Novartis buys AveXis in $8.7 billion gene therapy bet
Business Insider Apr 9, 2018
Why Did Novartis Spend $9 Billion On Gene Therapy? CEO Says: 'A Journey To Focus On Data And Digital'
Forbes Apr 9, 2018
Novartis Bets $8.7B on AveXis's Gene Therapy for Spine Disease
Xconomy Apr 9, 2018
Nationwide Children's sold stock, won't get $100M windfall in $8.7B acquisition of gene therapy spinoff
Columbus Business First Apr 9, 2018
Novartis CEO Vas Narasimhan cuts loose an old anchor and sets sail with $8.7B AveXis buyout
Endpoints News Apr 9, 2018
Why the Deal for AveXis Is a Powerful Vote for Replacement Gene Therapy
Barron's Apr 9, 2018
How a Rockville company benefits from Novartis' $8.7B purchase of a Chicago biotech
Washington Business Journal Apr 9, 2018
A small boutique landed a lucrative lead role on the $8.7 billion Novartis-AveXis deal
Markets Insider Apr 9, 2018
Biotech Buyer Prays a Monster Premium Will Be Enough: Gadfly
Washington Post Apr 9, 2018
Novartis upping presence in gene therapies through $8.7bn AveXis buy
In-PharmaTechnologist.com Apr 10, 2018
AveXis and Its Potential ALS Gene Therapy to Be Purchased by Novartis for $8.7B
ALS News Today Apr 9, 2018
Recon: Novartis to Acquire Gene Therapy Company AveXis for $8.7B
Regulatory Focus Apr 9, 2018
Deutsche Bank, Novartis, AveXis, Facebook, Patrick Reed - 5 Things You Must Know
TheStreet.com Apr 9, 2018
Novartis inks $8.7B AveXis buyout to build gene therapy unit
FierceBiotech Apr 9, 2018
Gene-therapy company with research ties to Columbus sold to Novartis for $8.7 billion
The Columbus Dispatch Apr 10, 2018
AveXis Pops 80% On Novartis Buyout As Celgene Rumored To Eye Others
Investor's Business Daily Apr 9, 2018
Novartis CEO Spurs Rare-Disease Shift With $8.7 Billion Deal
Bloomberg Apr 9, 2018
Pharmalittle: Novartis pays $9 billion for gene therapy company; Merck's Keytruda scores a win
STAT Apr 9, 2018
Novartis to acquire US gene therapy firm AveXis for $8.7bn
Pharmaceutical Business Review Apr 9, 2018
Novartis Gambles $8.7 Billion on Gene-Therapy Firm
24/7 Wall St. Apr 9, 2018
Novartis Wager on AveXis Shows Rare Diseases Command Mega Prices
Bloomberg Apr 9, 2018
Swiss giant Novartis to buy Bannockburn-based gene therapy company AveXis in $8.7B deal
Chicago Tribune Apr 9, 2018
Bannockburn gene therapy company sold for $8.7 billion
Chicago Daily Herald Apr 9, 2018
Novartis takes new route in €7bn deal
Irish Examiner Apr 10, 2018
Novartis bets big on gene therapy with $8.7bn AveXis deal
Independent.ie Apr 10, 2018
Novartis and AveXis Merge Spells Opportunity for SMA Research
Rare Disease Report Apr 9, 2018
AveXis' Share Price Soars with Acquisition Announcement
Investing News Network Apr 10, 2018
Novartis to buy AveXis for $8.7 billion
Fox Business Apr 9, 2018
Novartis buys US gene therapy group AveXis for $8.7bn
Financial Times Apr 9, 2018
Novartis to buy US gene therapy group AveXis for $8.7 bn
Yahoo Finance Apr 9, 2018
Novartis to acquire gene therapy specialist AveXis for $8.7bn
The New Economy Apr 9, 2018
Novartis buying AveXis for $8.7 billion to strengthen gene therapy capabilities
STAT Apr 9, 2018
Novartis Inks $8.7 Billion Gene Therapy Deal to Buy AveXis
Zacks.com Apr 9, 2018
Novartis Agrees to Buy AveXis in $8.7 Billion Deal
TheStreet.com Apr 9, 2018
Novartis to acquire gene therapy leader AveXis for $8.7B
UPI.com Apr 9, 2018
Novartis to buy AveXis in $8.7bn US gene-therapy deal
Irish Times Apr 9, 2018
AveXis Inc Stock Skyrockets on Novartis Deal
Investorplace.com Apr 9, 2018
Novartis to Acquire AveXis (AVXS) for $8.7 Billion
StreetInsider.com Apr 9, 2018
Novartis to buy US gene therapy group for $8.7 bln
Hurriyet Daily News Apr 9, 2018
Novartis buying AveXis for $8.7B in big gene therapy bet
KING5.com Apr 9, 2018
Novartis pays big premium to get hands on AveXis in US$8.7b deal
The Straits Times Apr 9, 2018
Novartis adds gene therapy for spinal muscular atrophy with $8.7B acquisition of AveXis
MedCity News Apr 9, 2018
Novartis to buy AveXis in US$8.7b gene therapy deal
Malay Mail Apr 9, 2018
Morning Movers: AveXis Soars on Novartis Takeover, Boeing Bounces, Leucadia Leaps
Barron's Apr 9, 2018
Novartis to buy AveXis in £6.2bn gene-therapy deal
Telegraph.co.uk Apr 9, 2018
Video: Jim Cramer Reacts to Novartis' Acquisition of AveXis
TheStreet.com Apr 9, 2018
Novartis makes $8.8bn bet on gene therapies with takeover of Avexis
The Times Apr 9, 2018
Mid-Morning Market Update: Markets Open Higher; Novartis To Acquire AveXis For $8.7B
Nasdaq Apr 9, 2018
Why The Novartis-AveXis Deal Is Good News For The Gene Therapy Space
Benzinga Apr 9, 2018
Additional jobs to be added to Oman's expat visa ban list
Arab News Apr 9, 2018
Novartis (NVS) Expected to Announce Earnings of $1.33 Per Share
The Ledger Gazette Apr 8, 2018
Novartis to buy AveXis for $8.7B
BSA bureau (press release) Apr 9, 2018
Novartis to Buy AveXis in $8.7 Billion Deal
GuruFocus.com Apr 9, 2018
Novartis expands in gene therapy and neuroscience with $8.7 billion acquisition
The Pharma Letter Apr 9, 2018
Novartis shells out $8.7 billion to buy AveXis
Economic Times Apr 9, 2018
Novartis buys neurology biotech AveXis for $8.7bn
pharmaphorum Apr 9, 2018
Swiss drugmaker Novartis snaps up US gene therapy firm AveXis for $8.7bn
City A.M. Apr 9, 2018
Novartis to pay $8.7 billion for gene-therapy company AveXis
Livemint Apr 9, 2018
Novartis bets big on gene therapy with $8.7bln AveXis deal
ZAWYA Apr 9, 2018
Novartis Acquires Gene Therapy Company for $8.7B
Investopedia (blog) Apr 9, 2018
Novartis to buy US gene therapy group AveXis for US$8.7 billion
Free Malaysia Today Apr 9, 2018
Novartis buys gene therapy firm AveXis for $8.7bn
PMLiVE Apr 9, 2018
Novartis acquires AveXis Inc for $8.7bn, aims to become a leader in gene therapy
Healthcare Global - Healthcare News, Magazine and Website Apr 9, 2018
Novartis pays 88% premium to gain control of AveXis
Proactive Investors UK Apr 10, 2018
Novartis To Purchase AveXis For $8.7 Bln Cash - Quick Facts
Nasdaq Apr 9, 2018
Novartis to buy AveXis in $8.7bn USA gene-therapy deal
Іnsіdеr Cаr Nеws Apr 9, 2018
Assessing the Performance of Novartis Stock in 1Q18
Market Realist Apr 9, 2018
Swiss drugmaker owns Gene therapy company
GkMen Apr 9, 2018
Novartis snaps up AveXis in $8.7bn deal
PharmaTimes Apr 9, 2018
Novartis AG to buy AveXis Inc for $8.7 billion
Nasdaq Apr 9, 2018
Novartis to Acquire AveXis for $8.7 Billion
Drug Discovery & Development Apr 9, 2018
Novartis announces takeover of AveXis
10,000 Couples Apr 9, 2018
Novartis share price: Swiss pharma giant buys AveXis for its spinal muscular atrophy drug
Verdict Apr 9, 2018
AveXis Inc to be Acquired by Novartis AG – Shares Skyrocket
StreetSignals Apr 10, 2018
Novartis enters agreement to acquire AveXis Inc. for USD 8.7 bn to transform care in SMA and expand position as a ...
WebWire (press release) Apr 9, 2018
Novartis to Buy Gene Therapy Company AveXis for $8.7 Billion
ExpressNewsline Apr 9, 2018
AveXis Soars on Purchase by Novartis
Baystreet.ca Apr 9, 2018
Novartis bets big on gene therapy with US$8.7bil AveXis deal
The Star Online Apr 9, 2018
Should You Buy Novartis AG (NYSE:NVS)?
Simply Wall St Apr 9, 2018
Drugmaker Novartis acquires AveXis for USD 8.7 bln
Business Review Apr 10, 2018
Hoylecohen LLC Purchases Shares of 3184 Novartis (NYSE:NVS)
The Ledger Gazette Apr 9, 2018
How Less Risky is Your Stock?: Novartis AG (NVS)
Wallstreet Investorplace Apr 9, 2018
Verition Fund Management LLC Acquires New Position in Novartis (NVS)
StockNewsTimes Apr 10, 2018
Healthcare Stock Roundup: Novartis AG (NVS)
StocksGeeks (press release) Apr 9, 2018
Novartis Acquires AveXis for $8.7 Billion
StockNewsTimes Apr 9, 2018
Novartis (NVS) Shares Sold by BB&T Securities LLC
StockNewsTimes Apr 10, 2018
$1.33 Earnings Per Share Expected for Novartis (NVS) This Quarter
Macon Daily Apr 10, 2018
Novartis to buy AveXis in $8.7bn United States gene-therapy deal
ClickLancashire Apr 9, 2018
Novartis (NYSE:NVS) Shares Sold by Sawtooth Solutions LLC
registrarjournal.com Apr 9, 2018
Critical Contrast: OPKO Health (OPK) vs. Novartis (NYSE:NVS)
StockNewsTimes Apr 9, 2018
Verity & Verity Has Upped By $1.21 Million Its Target (TGT) Stake; Usca Ria Has Raised Novartis AG (NVS) Holding By ...
San Times Apr 9, 2018
Novartis to Spend $8.7 Billion on New De
FSM News (blog) Apr 9, 2018
Outfitter Advisors LTD Increased Holding in Smucker JM Co (SJM); As Novartis Ag Adr (NVS) Shares Declined, Ct ...
FlintDaily.com Apr 9, 2018
Analysts See $1.32 EPS for Novartis AG (NVS); Bluefin Trading Upped Its Twitter (Call) (TWTR) Stake
Thorold News Apr 9, 2018
Wells Fargo & Co. (WFC) Market Valuation Declined While Schafer Cullen Capital Management Boosted Holding by ...
FlintDaily.com Apr 9, 2018
Lido Advisors LLC Buys New Holdings in Novartis (NVS)
Week Herald Apr 9, 2018
Pekin Singer Strauss Asset Management Lowered By $376903 Its Novartis AG (NVS) Holding; Moore Capital ...
Thorold News Apr 9, 2018
Novartis (NVS) Shares Sold by Sterling Capital Management LLC
StockNewsTimes Mar 27, 2018
Novartis buys US gene therapy firm AveXis
The Straits Times Apr 9, 2018
AveXis Inc surges 80% on Novartis AG acquisition
Investorsquawk (blog) Apr 9, 2018
Grimes & Company INC Increased Novartis Ag (NVS) Holding by $4.22 Million
Reurope Apr 9, 2018
Ledyard National Bank Decreased Whirlpool (WHR) Holding; Managed Asset Portfolios Has Lifted By $360718 Its ...
Thorold News Mar 25, 2018
Featured Videos
Search
Clear search
Close search
Google apps
Main menu